A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
New Hope for Ovarian Cancer: FDA Approves Targeted Drug ELAHERE for Certain Patients With Difficult-to-Manage Disease
NOW
PLAYING
FDA Approves Breyanzi - The First and Only CAR-T Cell Therapy To Show Promise For CLL Patients
NOW
PLAYING
What You Need to Know About the New Drug for Myelodysplastic Syndrome
NOW
PLAYING
Advanced Liver Cancer Diagnosis, Treatment & Symptom Management
NOW
PLAYING
Amtagvi Shows Promise For Treating Metastatic Melanoma
NOW
PLAYING
FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.